iShares Nasdaq Biotechnology ETF (IBB)
| 148.73 Delayed Data As of Apr 09 |  -0.66 / -0.44%Today’s Change | 112.39 Today|||52-Week Range 174.04 | -1.82% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Rye Brook Capital LLC Buys VanEck Vectors Semiconductor ETF, Vanguard Consumer Discretionary ... Apr 09 / GuruFocus News - Paid Partner Content | Moderna ETFs to Gain on Positive 'Real-World' Study Data Mar 30 / Zacks.com - Paid Partner Content |
| Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus Apr 08 / Zacks.com - Paid Partner Content | Will ETFs Gain on AstraZeneca's Latest Covid-19 Vaccine Update? Mar 29 / Zacks.com - Paid Partner Content |
| Is Gilead Sciences Stock a Buy? Apr 08 / MotleyFool.com - Paid Partner Content |
Performance
| 1 month | +1.47% | 3 years | +14.13% | |
| 3 months | -5.56% | 5 years | +10.30% | |
| 1 year | +32.49% | Since inception | +7.88% |
Data through 04/09/2021
Quote Details
| Previous close | $149.39 |
| Open day’s range | 147.85 – 149.30 |
| Net asset value (NAV) | 149.20 (04/08/2021) |
| Daily volume | 4,062,753 |
| Average volume (3 months) | 3,162,974 |
Data as of 04/09/2021
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +10.30% | +15.28% |
| Expense Gross exp ratio | 0.46% | 1.02% |
| Risk 5 year sharpe ratio | 0.57 | 0.80 |
| Net assets | $10.0B | $2.3B |
| Average market cap | $16.2B | $31.9B |
| Average P/E | 24.5 | 27.0 |
| Dividend / Share | -- | 0.29% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| PSCH Invesco S&P SmallCap Health Care ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen | 9.25% |
| GILD Gilead Sciences | 6.85% |
| ILMN Illumina Inc | 4.73% |
| VRTX Vertex Pharmaceuticals Inc | 4.71% |
| MRNA Moderna Inc | 4.42% |
| REGN Regeneron Pharmaceuticals | 4.20% |
| BIIB Biogen | 3.60% |
| ALXN Alexion Pharmaceuticals Inc | 2.84% |
| SGEN Seagen Inc | 2.12% |
| AZN AstraZeneca | 1.92% |
